AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2023

Dec 18, 2023

30198_dirs_2023-12-18_98dd4d0d-32cf-49a8-823c-34bc8e0f982a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2023-12-15

Reporting Person: AUGUSTINOS NICHOLAS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-15	Common Stock	S	3976	$123.02	Disposed	34040	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3043	Direct

Footnotes

F1: On September 15, 2023, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.